The stock opened at Rs 922.9 and touched an intraday high and low of Rs 944.0 and Rs 910.25, respectively, in the session so far. Shares of the company of Aurobindo Pharma Ltd. quoted a 52-week high of Rs 1023.1 and a 52-week low of Rs 510.45.
As per BSE, the total market cap of the Aurobindo Pharma Ltd. stood at Rs 55136.82 crore at the time of writing this report.
The company reported consolidated sales of Rs 6498.31 crore for the quarter ended 31-Dec-2020, down 0.59 per cent from previous quarter’s Rs 6537.19 crore and down 9.66 per cent from the year-ago quarter’s Rs 5925.93 crore.
The net profit for latest quarter stood at Rs 2946.46 crore, up 317.67 per cent from the corresponding quarter last year.
As of 31-Dec-2020, domestic institutional investors held 9.94 per cent stake in the company, while foreign institutional investors held 24.99 per cent and the promoters 48.86 per cent.
According to BSE data, the stock traded at a P/E multiple of 10.24 and a price-to-book ratio of 1.44. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Aurobindo Pharma Ltd. belongs to the Pharma – Indian industry.